Caffeine as a psychomotor stimulant: mechanism of action.
about
Dopamine dysregulation in a mouse model of paroxysmal nonkinesigenic dyskinesiaFunctional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humansAdenosine A2A receptors and basal ganglia physiologyTime and sex-dependent effects of an adenosine A2A/A1 receptor antagonist on motivation to self-administer cocaine in rats.Role for Rab10 in Methamphetamine-Induced BehaviorA2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activationDipyridamole monotherapy in schizophrenia: pilot of a novel treatment approach by modulation of purinergic signaling.What users think about the differences between caffeine and illicit/prescription stimulants for cognitive enhancement.Sleep loss produces false memories.Caffeine and a selective adenosine A2A receptor antagonist induce sensitization and cross-sensitization behavior associated with increased striatal dopamine in mice.Mobilization of calcium from intracellular stores facilitates somatodendritic dopamine release.Effects of paraxanthine and caffeine on sleep, locomotor activity, and body temperature in orexin/ataxin-3 transgenic narcoleptic miceChronic caffeine ingestion causes microglia activation, but not proliferation in the healthy brainMechanisms mediating the ability of caffeine to influence MDMA ('Ecstasy')-induced hyperthermia in ratsGenetics of caffeine consumption and responses to caffeine.Caffeinated Alcoholic Beverages - An Emerging Trend in Alcohol Abuse.Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine.Practical use and risk of modafinil, a novel waking drug.Effects of 28-days ingestion of a slow-release energy supplement versus placebo on hematological and cardiovascular measures of health.Effects of caffeine on circadian phase, amplitude and period evaluated in cells in vitro and peripheral organs in vivo in PER2::LUCIFERASE mice.Osteogenic potential of osteoblasts from neonatal rats born to mothers treated with caffeine throughout pregnancyPathway-specific effect of caffeine on protection against UV irradiation-induced apoptosis in corneal epithelial cells.Caffeine increases the temporal variability of resting-state BOLD connectivity in the motor cortexPolymorphisms of ADORA2A modulate psychomotor vigilance and the effects of caffeine on neurobehavioural performance and sleep EEG after sleep deprivation.Exercise-Induced Fatigue and Caffeine Supplementation Affect Psychomotor Performance but Not Covert Visuo-Spatial AttentionInfluence of coffee drinking and cigarette smoking on the risk of primary late onset blepharospasm: evidence from a multicentre case control studyA Methodological Discussion of Caffeine Research and Animal Avoidance Behavior.Caffeine enhances the antidepressant-like activity of common antidepressant drugs in the forced swim test in miceCaffeine and risk of Parkinson's disease in a large cohort of men and women.Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humansGender differences in tea, coffee, and cognitive decline in the elderly: the Cardiovascular Health Study.Caffeine-Induced Suppression of GABAergic Inhibition and Calcium-Independent Metaplasticity.An undergraduate laboratory exercise examining the psychomotor stimulant effects of caffeine in laboratory ratsNeuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A2A receptors.Caffeine-induced endothelial cell death and the inhibition of angiogenesis.A Preliminary Study on the Effects of Self-Reported Dietary Caffeine on Pain Experience and Postoperative AnalgesiaCaffeine stimulates locomotor activity in the mammalian spinal cord via adenosine A1 receptor-dopamine D1 receptor interaction and PKA-dependent mechanisms.Is DARPP-32 a potential therapeutic target?Dietary supplement increases plasma norepinephrine, lipolysis, and metabolic rate in resistance trained men.Effects of chronic caffeine exposure on adenosinergic modulation of the discriminative-stimulus effects of nicotine, methamphetamine, and cocaine in rats.
P2860
Q24300992-DE110043-18B5-4638-A1AD-D282A2961B48Q24654140-1832442C-DB3D-42B6-96F3-988C3159DFC0Q24669783-3ADCFC2E-CC3C-4F6C-98C7-0152E3E1AFE4Q28266492-F1415FC6-E45C-4E24-A9EF-B7268B7FD40DQ28547376-7C4FCD25-EE7B-419F-B859-810382FD00F2Q28728678-CCFC4D56-0372-4BDD-948A-02735AE071B2Q30438924-6232BC59-61AE-40F9-AC10-27F1B6AB6F14Q30465974-3C73B19D-BAAA-4979-8EBC-0A1420974F4CQ33378910-65D69838-8DEB-41A7-9F6D-3CBDDFCE6CE1Q33745754-F70B190A-AA36-4535-9912-64AA9706D6F4Q33943986-93DED5BB-EAF9-4F43-81E6-BA87D90F27E2Q33950203-6FCDE6E4-8720-4249-8169-762C8005846DQ33954408-59B838FC-67E3-4170-9C24-B655160766F2Q34112855-44B97E8A-525E-4A0C-8781-208EC17BFF2EQ34119748-3213E2BC-14A3-4C3B-B953-CAAB749F8E9AQ34546910-4C7F68AA-DB06-4BF1-A4A5-BDC6F9C3C5AEQ34558649-E99F971E-76E9-4706-B89C-A9939E137767Q34636243-40FD9A51-A62D-42F7-9A01-1363C15C536CQ34728072-1388F5F3-4755-4997-ADBB-87002D33F55BQ34914328-E7535099-8EBB-4C02-84A9-BE2409042D74Q35072810-0B5FAD55-AA6F-42BC-8D3E-35D483A9F0C6Q35894504-84EDF467-8E99-4CAF-B905-1F012598A858Q35954666-D7B9236B-C010-47C8-97CD-5798500570A7Q36025395-30103D37-A81C-4A34-91AA-208403868BB4Q36170864-C4A40599-E613-43D7-A7EB-A60745077395Q36227210-EE95F732-5907-44C2-848F-4DB8ABD17D87Q36330087-2A6D5697-D294-4290-9498-1F0964A19F6DQ36471008-DC98E76A-ECF8-4C26-AB4D-8371BA69AA68Q36560201-153671CA-4150-4B6B-9145-E853B8FF89E3Q36581904-700EE98F-74E9-4EC4-9F82-0BCD1ADC2E06Q36623334-658A3BDB-0F5B-4E43-8D6E-EB0AE53AAE82Q36655474-CBEC23A0-F330-406F-8294-815AA635E991Q36685968-1E7850CE-7A48-4943-A1F0-CD034452509BQ36723079-D0950681-5EA6-445C-9B76-E50A3FA0824BQ36737785-0CE44869-EC4C-4F5C-8929-CA0DAF558D2FQ36752651-FAFD6C9A-151C-424D-BEA9-5082561754EDQ36865810-DE683FB3-5DE0-4E03-A59C-1F5919BB83DDQ37004761-72FD5674-5915-4F08-87CB-9B5CBE1B6A55Q37103783-54542EAF-0E27-4E2A-A894-EBFE82B83223Q37130072-3CAAF436-335F-41E9-8B32-1626EF8B6D2E
P2860
Caffeine as a psychomotor stimulant: mechanism of action.
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Caffeine as a psychomotor stimulant: mechanism of action.
@ast
Caffeine as a psychomotor stimulant: mechanism of action.
@en
Caffeine as a psychomotor stimulant: mechanism of action.
@nl
type
label
Caffeine as a psychomotor stimulant: mechanism of action.
@ast
Caffeine as a psychomotor stimulant: mechanism of action.
@en
Caffeine as a psychomotor stimulant: mechanism of action.
@nl
prefLabel
Caffeine as a psychomotor stimulant: mechanism of action.
@ast
Caffeine as a psychomotor stimulant: mechanism of action.
@en
Caffeine as a psychomotor stimulant: mechanism of action.
@nl
P1476
Caffeine as a psychomotor stimulant: mechanism of action
@en
P2093
P2888
P304
P356
10.1007/S00018-003-3269-3
P577
2004-04-01T00:00:00Z